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Abstract. Simulating images representative of neurodegenerative dis-
eases is important for predicting patient outcomes and for validation of
computational models of disease progression. This capability is valuable
for secondary prevention clinical trials where outcomes and screening
criteria involve neuroimaging. Traditional computational methods are
limited by imposing a parametric model for atrophy and are extremely
resource-demanding. Recent advances in deep learning have yielded data-
driven models for longitudinal studies (e.g., face ageing) that are capable
of generating synthetic images in real-time. Similar solutions can be used
to model trajectories of atrophy in the brain, although new challenges
need to be addressed to ensure accurate disease progression modelling.
Here we propose Degenerative Adversarial NeuroImage Net (DaniNet)
— a new deep learning approach that learns to emulate the effect of
neurodegeneration on MRI by simulating atrophy as a function of ages,
and disease progression. DaniNet uses an underlying set of Support Vec-
tor Regressors (SVRs) trained to capture the patterns of regional in-
tensity changes that accompany disease progression. DaniNet produces
whole output images, consisting of 2D-MRI slices that are constrained
to match regional predictions from the SVRs. DaniNet is also able to
maintain the unique brain morphology of individuals. Adversarial train-
ing ensures realistic brain images and smooth temporal progression. We
train our model using 9652 T1-weighted (longitudinal) MRI extracted
from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset.
We perform quantitative and qualitative evaluations on a separate test
set of 1283 images (also from ADNI) demonstrating the ability of Da-
niNet to produce accurate and convincing synthetic images that emulate
disease progression.
*Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimag-
ing Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI
contributed to the design and implementation of ADNI and/or provided data but did not partic-
ipate in analysis or writing of this report. A complete listing of ADNI investigators can be found
at: http://adni.loni.usc.edu/wp-content/uploads/how˙to˙apply/ADNI˙Acknowledgement˙List.pdf
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1 Introduction
Neurodegenerative diseases are strongly age-related, and the incidence of these
diseases is expected to rise in the next few years due to increasing life expectancy.
Creating tools that assist our limited understanding of neurodegeneration can
help to answer some of the open questions in this field, e.g., What are the causes?
How can we improve subtype classification?
Disease progression modelling [7] analyzes clinical and image-based biomark-
ers to map out longitudinal changes during chronic diseases. However, modelling
temporal neurodegeneration on full resolution MRI is still a major challenge.
To tackle this problem, a few simulators have been proposed in the litera-
ture [3,4,8,6]. The recent SimulAtrophy [5] uses a computational model based
on fluid mechanics. This approach combines two deformation fields: one from a
biophysical model and the other obtained by non-rigid registration of two real
images. For a given baseline MRI, the combined deformation field is used to
impose the desired level of atrophy and generate the simulated image. SimulA-
trophy is extremely resource-demanding and is not scalable to high-resolution
images. Exploiting the success of deep learning, Bowles et al. [2] proposed a
framework based on Generative Adversarial Networks (GANs) to model and
manipulate MRI directly through the technique of image arithmetic. Although
the system is able to introduce or remove atrophy patterns from regions in the
brain, it presents a few important limitations: disease progression is modelled
linearly and morphological changes are the same across all patients. A more ad-
vanced deep learning framework developed to predict face ageing was proposed
in [9]. Our idea is to use a similar framework to generate realistic images that also
preserve biological/anatomical constraints associated with disease progression.
In this paper we present a new framework that overcomes the limitations
of existing approaches. Firstly, similar to [9] we employ adversarial training to
ensure a high level of realism in the synthetic MRI. Secondly, we avoid imposing
predefined atrophy patterns, prefering to implement novel biological constraints
that model neurodegeneration. These constraints control the MRI intensity in
each brain region through a set of localised SVRs learnt directly from the data.
Finally, we design DaniNet to handle non-imaging characteristics, which we em-
ploy here to condition upon age and diagnosis. Experiments evaluate the per-
formance of the various components of DaniNet and demonstrate the ability to
produce accurate and realistic synthetic images that emulate disease progression.
2 Methods
In this section we present the main blocks which compose DaniNet. A colour-
coded work-flow of our system is depicted in Fig. 1.
The first pre-processing block (shown in blue in Fig. 1) extracts a normalized
slice x from the MRI I. The second component (shown in grey) is a Conditional
Deep Autoencoder (CDA) composed of two deep neural networks: an encoder E
that embeds x in a latent space Z, and a generator G that projects the vectors
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Fig. 1. Pipeline used for training the proposed DaniNet framework. Each component
of the pipeline is identified by a different colour.
produced by E back to the original manifold. Before this projection, the latent
vector z is conditioned with two variables: i) d — a numerical representation
[0-3] of diagnosis (i.e. cognitively normal, subjective memory concern, early/late
mild cognitive impairment, Alzheimer’s disease); and ii) a ∈ [1, A] — an index
describing age, binned into A=10 groups. This age discretisation is important
for computing deformation loss (block in yellow) to learn morphological changes
along the progression. The third component (shown in green), consists of two
discriminator networks: i)Dz that drives E to produce z with a uniform prior and
smooth temporal progression; and ii) Db that drives G to produce realistic brain
neuroimages. Finally, in the blocks coded in orange, we present the proposed
biological constraints used to model disease progression. In the next sub-sections,
we will describe each of these components in detail.
2.1 Pre-processing
The pre-processing block removes irrelevant variation on the data and ensures
that intensity values in each voxel only decrease. In an ideal scenario, intensity of
T1-weighted MRI decreases with age since tissue density (having high intensity)
will reduce, while water content (having low intensity) will increase. However,
due to scanner variability and other sources of noise, this may not be the case
in practice. To handle these variabilities, each input image is normalised using
the following pre-processing steps: i) linear co-registration to a 1mm isotropic
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Fig. 2. Pipeline used to obtain the proposed image biomarkers based on regional-based
intensity progression.
MNI template using FLIRT-FSL, ii) skull-stripping using BET-FSL, and iii)
intensity normalisation to zero mean and unit standard deviation. Images where
pre-processing failed were not included in the training set.
2.2 Conditional Deep Autoencoder
A CDA is an extension of the Deep Autoencoder (DA) with the ability to inte-
grate conditional variables inside the generator G. The advantage of training a
single end-to-end CDA over training separate DAs is that it avoids overfitting
individual groups when longitudinal data are missing. For the architecture of E
and G we follow [9]. The output of the encoder E is a feature vector z ∈ Rs
that preserves the brain morphology of the current participant. The output of
G are synthetic images defined as ga = G(E(x), a, d). The aim of G is to learn
the mapping between the linear transition of the latent vector conditioned on a
and d and the non-linear transition in the original manifold.
2.3 Adversarial Training
Again following [9], DaniNet includes two discriminator networks that are trained
adversarially with the CDA. The first discriminator Dz guides E to generate z
with a uniform distribution U to ensure temporal smoothness, as demonstrated
in [9]. Specifically, Dz is trained to distinguish the vector generated by the en-
coder E from samples extracted from U. On the other side, E is trained in a
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zero-sum game with the purpose to fool Dz. The objective function used for this
adversarial training is
min
E
max
Dz
Ez∗ [ logDz(z∗)] + Ex[1− logDz(E(x))], (1)
where E is the expectation operator, z∗ is a vector sampled from U, Dz esti-
mates the probability that a vector comes from U, and E(x) is the latent vector
obtained from x.
The second discriminator Db guides the generator G to produce realistic
brain images. This discriminator is trained to distinguish the synthetic images
ga from the real images in the training set via the following objective function
min
G
max
Db
Ex[ logDb(x))] + Ex[1−Db(G(E(x), a, d))], (2)
where Db estimates the probability that a slice is extracted from a real MRI.
2.4 Biological Constraints
To capture the patterns of image intensity changes that accompany disease pro-
gression, our framework uses two separate loss functions during training. These
loss functions impose biological constraints that mimic neurodegeneration by
ensuring decreased intensity (tissue density) that is consistent with disease pro-
gression.
The first loss function operates at the voxel level. Given a synthetic output
ga in age group a, we impose that corresponding voxels of each preceding image
gi with i < a have higher-intensity values. Likewise, later images gj with j > a
have lower-intensity values. We express this constraint as
Lvox =
1
MN(A− 1)
[ a−1∑
p=1
sgn(ga − gp) +
A∑
p=a+1
sgn(gp − ga)
]
, (3)
where M and N are the number of rows and columns in each slice, and sgn is
the sign function.
The second loss function operates at a regional level to improve spatial con-
sistency across neighbouring voxels. We pre-train a set of SVRs to learn how to
predict the rate of intensity progression in fixed, overlapping, data-driven regions
mask obtained from hierarchical clustering of local intensity of the training im-
ages. On the considered axial slice the clustering algorithm detects 128 regions
with an average size of 233 voxels. We train one SVR per region, where the input
features are the age at baseline, the age at the follow-up, and diagnosis d. We
restrict the SVR training to monotonically decreasing data by removing time-
points where regional intensity increases. The loss function used to constrain the
image sequence gi (with i ∈ [1, A]) through the regional SVR predictions is
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Lreg =
1
R(A− 1)
R∑
i=1
[ a−1∑
p=1
(
SVRi(p, a, d)−
∑
[ga · ri] + ∑
[gp · ri] + 
)
+
A∑
p=a+1
(
SVRi(a, p, d)−
∑
[gp · ri] + ∑
[ga · ri] + 
)]
, (4)
where R is the number of regions, ri is the i-th region-mask, SV Ri(p, a, d) is
the prediction of intensity rate progression for the region i, and  = 0.1 avoids
division by 0.
The pre-trained SVRs supply a set of constraints on the generator’s out-
puts for ensuring accurate emulation of neurodegeneration. The process used to
compute the rate of regional intensity progression is summarized in Fig. 2.
2.5 Deformation Loss
Our final loss function ensures consistency with the individual subject over time
by minimising the difference between individual input image sequences and the
corresponding output sequences. For each input image x, the difference is min-
imised between x and a weighted average of two outputs from the nearest age
bins:
Ldef = L2
(
x, [gaα+ ga+1(1− α)]
)
, (5)
where α reflects the distance between input age and the group a and a+ 1.
In summary, the loss functions Lreg and Lvox ensure monotonic intensity
change to mimic neurodegeneration, and Ldef together with Db ensure realistic
brain morphology.
2.6 Training Details, Parameters and Evaluation
Data used in the preparation of this article were obtained from the ADNI
database (adni.loni.usc.edu). The ADNI was launched in 2003 as a public-private
partnership, led by Principal Investigator Michael W. Weiner, MD. The primary
goal of ADNI has been to test whether serial magnetic resonance imaging (MRI),
positron emission tomography (PET), other biological markers, and clinical and
neuropsychological assessment can be combined to measure the progression of
mild cognitive impairment (MCI) and early Alzheimer’s disease (AD).
Training data (MRI-slices: 9852; participants: 876) and testing (MRI-slices:
1283; participants: 179) are pre-processed T1-weighted MRI from the ADNI
dataset. This includes data from multiple sites, scanners, and pre-processing
pipelines. We included them all to improve robustness to such variability, and
hence increase generalizability. The participants were aged between 63 and 87
years old, with the following distribution of clinical disease stage: 28% cognitively
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Table 1. Performance of DaniNet on different configurations.
S
S
IM
[9] C T C-T P P -C P -T P -C-T
0.43 ±
0.07
0.44 ±
0.06
0.59 ±
0.14
0.60 ±
0.14
0.44 ±
0.08
0.48 ±
0.08
0.61 ±
0.15
0.62 ±
0.16
normal, 4% subjective memory concern, 54% mild cognitive impairment and 14%
Alzheimer’s disease. Each participant has on average 4.7 MRI spanning 3 years.
We select participants in the test set having at least one follow-up visit two years
after baseline, to allow sufficient time for observable neurodegeneration to occur.
The architectures of each network E, G, Db, DZ are based on the imple-
mentation proposed in [9]. The size of the latent space Z is fixed to 200. The
network’s parameters of E and G are trained to minimize a total loss defined as
Ltot = Ez ∗ 0.0003 +Gb ∗ 0.0003 +Lvox ∗ 0.0003 +Lreg ∗ 0.0003 +Ldef ∗ 0.2 (6)
where Ez is the cross entropy obtained by the discriminator Dz on the generated
latent vectors, and Gb is the cross entropy obtained by the disctiminator Db on
synthetic images ga. To train our system we use the stochastic gradient descent
solver, ADAM (α = 0.0002, β1 = 0.5) on an NVIDIA GTX TITAN-X GPU
card. The training procedure converged after 3000 epochs of random mini-batch
of 100 slices with a size of 128×128. We also align each test individual to the
model by baseline age and diagnosis, then personalise DaniNet with a transfer
learning step (T component, see results section 3) that involves an additional
200 training iterations on the single baseline image. Personalisation is essential
to tune the model for the specific morphology of the individual’s brain, ready to
simulate realistic, personalised followup MRI. To note, only a single MRI from
each test subject’s first visit is used to personalise the trained model.
In our evaluation, input x are from baseline visits. Follow-up data is the
ground truth y against which we evaluate generated images gi using complemen-
tary quantitative and qualitative analysis. The quantitative analysis involves the
use of the Structural Similarity Index matrix (SSIM). Since this matrix is not
able to quantify the actual realism of the obtained images we also perform a com-
plementary qualitative analysis via a survey of clinicians and medical imaging
experts that evaluate the synthetic images based on their perception.
3 Results
Our first experiment is designed to show that DaniNet improves similarity be-
tween generated image and ground truth, with respect to the baseline approach
developed for face ageing [9]. Specifically, we evaluate the contribution obtained
by three components of DaniNet: i) P obtained exploiting Lvox and Lreg, ii) C
obtained conditioning the system with the clinical diagnosis, and iii) T obtained
when the learned model is transferred before testing on new data.
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Fig. 3. Visual results obtained by different configurations of DaniNet on MRI slices
from three participants in the test set.
For this purpose, the SSIM results obtained using different compositions of P ,
C, and T are reported in Table 1. Clearly, the best results are obtained when the
framework includes all three components. The baseline model produces inferior
SSIM. Transfer learning T is the feature that provides the highest contribution.
A moderate contribution is provided by P and C. These improvements were
assessed statistically using a paired t-test and all p-values were less than 0.0001.
Visual results for the configurations C-T , P -C-T and baseline [9] are shown in
Fig. 3. The error maps, shown in the last row of the figure, confirm our findings.
A full simulation with the optimal configuration P -C-T is shown in Fig. 4 where
neurodegeneration is apparent in the progression (left to right), most obviously
in ventricular expansion and cortical thinning.
Our second experiment tests the qualitative performance of DaniNet based
on human visual perception. In a survey, we asked 25 medical imaging experts
(neurologists and computer scientists) to evaluate on average 36 sets of three
images each, randomly selected from the test set, generated using two different
configurations of DaniNet (C-T and P -C-T ) and the baseline [9]. These were
shown to the user in a random order. The input x and the related follow-up
y were also displayed on the screen as references for the participants. For each
set of images, the user was asked to select the closest synthetic image to y.
Results from the survey confirm that DaniNet is a considerable improvement of
the baseline approach. The medical imaging experts selected the configuration
P -C-T 26± 5 (mean ± std) times (72± 14%), the configuration C-T 7± 4 times
(19±11%), and the baseline 1±1 times (3±3%). For only 2±3 outputs (6±8%)
the users were not happy with any of the generated synthetic images.
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Fig. 4. Neurodegeneration simulation of a 69-year old ADNI participant.
4 Conclusion and Future Work
We have proposed and evaluated (quantitatively and qualitatively) a novel deep-
learning framework that is able to learn how to emulate the effect of neurodegen-
erative disease progression on structural MRI. The framework produces person-
alised, realistic output images through a combination of biological constraints,
transfer learning, and conditioning upon both fixed and variable non-imaging
characteristics. To the best of our knowledge, we are the first to propose a simula-
tor that imitates realistic neurodegeneration by imposing biological constraints.
In future work we will extend the framework to simulate entire 3D-MRI with
the aid of low-memory techniques [1]. Additionally, focal brain pathologies, such
as glioma and white matter hyperintensities, are not currently modelled by our
framework; future work will extend to consider such effects. Finally, although
we have demonstrated our framework for modelling atrophy in MRI, we believe
that this solution can be used with different image modalities (e.g. PET, CT,
etc.) and to model disease progression on other organs (e.g lung, retina, etc.).
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